(Date:12/11/2009)... -- EntreMed, Inc. (Nasdaq: ENMD ), today ... revenue from sales of Thalomid® during the third ... million. In addition, the Company anticipates a ... fiscal 2009. The difference in estimated and ... reflected in the fourth quarter financial results. ,, ...
(Date:12/11/2009)... Biosciences Corporation announced today the enrollment and dosing at ... of the first patient in the ACE ( ... Phase 2 pivotal trial in patients with relapsed or ... novel, orally available, potent and highly selective small molecule ... (FLT3) inhibitor. The ACE study is designed to ...
(Date:12/11/2009)... Hatboro, PA December 11, 2009 -- Esco announces the opening of ... will serve as a technical service, training and logistics center to ... area of New Product Introductions (NPI) for temperature-controlled laboratory equipment. ... ... announces the opening of a NEW 2nd North American facility in ...
(Date:12/10/2009)... 10 With the economy and markets exhibiting ... largest, fastest-growing small cap equity research provider, will seek ... opportunities within the micro cap market at the firm,s ... 11, 2010 at the Grand Hyatt Hotel in New ... overlooked and undervalued by much of Wall Street, but ...
Breaking Biology Technology:EntreMed Reports Receipt of Third Quarter Royalty Payment 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Technology, Biotech, Energy and Transportation Among the Industries to be Featured at Sidoti & Company's First Annual 2010 Micro Cap Conference 2... Inc. (Nasdaq:,FVRL), a biopharmaceutical company developing patient-specific, active,immunotherapies ... it will,host a conference call and live webcast ... 2007 to discuss the Company,s third quarter 2007,financial ... 2007,financial results will be issued before the U.S. ...
... SOUTH SAN FRANCISCO, Calif., Oct. 16 Rigel,Pharmaceuticals, ... its scientists,will be presenting three poster presentations at ... Therapeutics in,San Francisco, October 22-26, 2007. They will ... including Axl receptor,tyrosine kinase (Axl), Polo- like kinase ...
... N.J., Oct. 16 National Stem,Cell Holding, Inc. ... patent application for a newly discovered group of,biomaterials, ... cell,lines, that may stimulate a variety of naturally ... ability to preserve and repair,itself . These ...
Other Biology Technology:Favrille to Host Conference Call and Live Webcast to Discuss Third Quarter 2007 Financial Results on October 25, 2007 2Rigel to Present Research Programs at Scientific Conferences 2Rigel to Present Research Programs at Scientific Conferences 3National Stem Cell Holding Announces Patent Application for Newly Discovered Cellular Derived Biomaterials for Anti-Aging Applications 2National Stem Cell Holding Announces Patent Application for Newly Discovered Cellular Derived Biomaterials for Anti-Aging Applications 3... an intuitive, easy-to-use operating environment ... data handling, and integration with ... include data acquisition, re-analysis, custom ... both standalone and network environments. ...
... poor quality running into billions of ... under increasing pressure to reduce expensive ... microscopic distribution of ingredients is known ... as dissolution, stability, bio-availability and hardness. ...
... number is a new product ... Cornings product number. If showing ... under the old Sigma-Aldrich number ... for assistance. ID clarifier: reusable ...
... kit allows a rapid and efficient ... FLAG-tagged protein. The immunoprecipitation is performed ... a highly specific monoclonal antibody covalently ... of affinity resin allows an efficient ...
Biology Products:Biology NavigationMedical Navigation